The APAC antibody identification market is experiencing robust growth, fueled by a increasing prevalence of chronic conditions and a enhanced focus on personalized medicine. Notable investment in research and development, particularly within countries like China, Japan, and South Korea, is driving the adoption of advanced antibody discovery platfor